Obstructive sleep apnoea is characterised by recurrent collapse of the pharynx that leads to at least five apnoeic episodes per hour of sleep, lasting from 10-90 seconds, and causing falls in arterial oxygen saturation, and sleep arousal. I The obesity hypoventilation syndrome is a small (5%) specialised subset of obstructive sleep apnoea,2 and is differentiated from the latter by the constancy of morbid obesity, daytime hypoxaemia and hypercarbia, polycythaemia, cor pulmonale 3 and a depressed ventilatory response to inhaled carbon dioxide. 4 Weight reduction in this clinical setting has led to improvements in gas exchange, pulmonary mechanics and haemodynamics, amelioration of daytime somnolence and irritability,5 and a significant reduction in the number of sleep disordered breathing events. 6 We describe a patient with the obesity hypoventilation syndrome, in whom gastric stapling and tracheostomy led to weight loss and amelioration of signs and symptoms.
With the tracheostomy stoma closed, daytime clinical improvement was maintained; however, at night, obstructive sleep apnoea reappeared.
The patient was a 23-year-old male admitted for elective gastroplasty and tracheostomy. He presented with obesity refractory to dietary manipulation, daytime somnolence and increasing shortness of breath with exertion. His family had noticed loud snoring of many years' duration, the severity of which had increased during the last several months. Studies at another hospital had documented two to four episodes of obstructive apnoea per minute of sleep, each lasting 10-20 seconds; concurrent with the apnoeic episodes were decreases in arterial oxygen saturation as measured by pulse oximeter, to 60 percent.
Past medical history included tonsillectomy and nasal septal reconstruction. He was currently being treated for epigastric burning and hypertension with ranitidine and triamterene hydrochlorthiazide respectively. There was no history of smoking.
On examination, the patient was an obese male in no apparent distress. His complexion was plethoric and there was mild peripheral oedema. Pulse was 71 beats/minute and regular, blood pressure 140/90 mmHg, and respiratory rate 20/minute. His weight and height were 144 kg and 175 cm respectively, yielding a body mass index of 47 (weight in kilograms/(height in metres)2). Breath sounds were clear. The second heart sound was loud at the pulmonic area and a right ventricular heave was present. The rest of the objective examination was unremarkable. Haemoglobin was 17.5 grams percent. Electrolytes, BUN, creatinine, liver and thyroid function studies were within normal limits. There was no biochemical evidence of Cushing's Disease.
The chest X-ray showed an enlarged right ventricle. The ECG was consistent with right ventricular hypertrophy and strain. Pulmonary function tests revealed a restrictive defect; FEV I was 3.05 litres and FVC 3.34 litres. The expiratory: inspiratory flow ratio at 50% vital capacity was 2.0, characteristic of variable extrathoracic upper airway obstruction. A ventilation/perfusion lung scan showed no evidence of chronic pulmonary emboli.
An otolaryngologist performed a fiberoptic nasopharyngoscopy, revealing adenoid hypertrophy, macroglossia, nasopharyngeal obstruction by the soft palate and an elongated 'U' shaped epiglottis.
Pulmonary and radial artery catheters were inserted. Baseline haemodynamics and arterial blood gases revealed mild He was taken to the operating room. Awake fiberoptic intubation was easily accomplished and anaesthesia was induced with thiopentone and maintained with fentanyl, pancuronium bromide and enflurane in 100% oxygen. Vertically banded gastroplasty and tracheostomy were accomplished without difficulty.
Mechanical ventilation was continued for five days after surgery. Complications included collapse of left lung relieved by bronchoscopic suctioning and a pseudomonas aeruginosa pneumonia treated with ceftazidime and tobramycin. Subcutaneous heparin was given and there was no evidence of postoperative deep vein thrombosis. Pulmonary artery pressure remained elevated at 90/50 mmHg. The elevated pressure was also refractory to sublingual nifedipine, and nitroglycerin infusion through the pulmonary artery catheter.
Oral intake was slowly advanced and he was discharged from hospital two weeks postoperatively.
The patient was readmitted four months later, for follow-up study. Since surgery, he had always slept with the tracheostomy tube 
DISCUSSION
The mechanism by which patients with obstructive sleep apnoea progress to the obesity hypoventilation syndrome is poorly understood. One postulated theory2 is that, as obesity worsens in the patient with obstructive sleep apnoea, so does the mechanical load on the respiratory system, and perhaps the amount of fatty tissue in the upper airway. Sleep-disordered breathing worsens and the hypoxic and hypercarbic ventilatory drives become blunted. Arterial blood gases, at first only abnormal during sleep, become abnormal during waking hours as well. Polycythaemia, pulmonary and systemic hypertension and CNS irritability intensify and the syndrome becomes fully established. Our patient demonstrated these cardiopulmonary changes, had gross upper airway pathology on fibreoptic examination, and pulmonary function test evidence of extrathoracic upper airways obstruction (FEF/FIF @ 50% VC> 1.0).
Pulmonary artery pressure did not decrease in the immediate postoperative period, despite normalisation of arterial blood gases, administration of sublingual nifedipine and nitroglycerin infusion through the pulmonary artery catheter. Both these agents are considered excellent pulmonary vasodilators 7 but were probably offset by the deleterious effects on pulmonary vascular resistance of a decrease in lung volume, mechanical ventilation, and the numerous pulmonary complications suffered.
When restudied, pulmonary artery pressure and pulmonary vascular resistance had markedly decreased and an electrocardiogram showed no evidence of right ventricular strain. This was undoubtedly due to the benefits of tracheostomy on pulmonary function. Administration of high concentrations of inspired oxygen did not result in C02 retention even with the tracheostomy tube closed; however, at night, he again suffered multiple episodes of obstructive sleep apnoea and the corresponding blood gas abnormalities appeared. His ventilatory response to hyperoxia appeared corrected albeit not accompanied by relief of nocturnal airway obstruction. When the tracheostomy tube was left open the following night, there was no abnormality in gas exchange detected.
Other modes of therapy for obstructive sleep apnoea include CPAP,8 nocturnal oxygen therapy,9 respiratory stimulants such as progesterone,IO acetazolamide,11 antidepressants such as protryptyline,12 and corrective surgery on the upper airway;13 the most popular procedure involves resection of redundant oropharyngeal tissue, the so-called uvulopalatopharyngoplasty. It is questionable whether our patient would respond to this operation as his upper airway obstruction was at multiple levels.
